| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bd4b708c5cfd5d1d0538d576a30297d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00 |
| filingDate |
2018-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5a22afc491e8fccfc4ed9293b5103ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9d131fa946ca32292a2019c4849942d |
| publicationDate |
2019-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110294785-A |
| titleOfInvention |
A kind of steroid ring expansion compound and preparation method thereof |
| abstract |
The present invention provides a steroid ring-expanded compound, which is characterized in that it has the structure described in formula I, or an enantiomer, solvate, or hydrate of the compound of formula I. The present invention has the advantages and positive effects that the compound of formula I can effectively bind to the glucocorticoid receptor to produce the same pharmacological action as the glucocorticoid; and its toxicity is lower than that of the glucocorticoid. |
| priorityDate |
2018-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |